Skip to main content
Equibles
RDNT logo

RDNT · RadNet, Inc. · Metrics

Track RDNT — free

Use RDNT with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research RDNT.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$73.18 +3.13 (+4.46%)
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$5.51B
Shares
78.70M
Volume · Oct 27 504.94K Avg daily vol (3M) 671.31K

RDNT metrics

94 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$70.05
Market cap
$5.51B

Price action

20 metrics
Price change (1W)
+1.1%
Price change (30D)
-2.5%
Price change (3M)
+13.9%
Price change (6M)
+21.3%
Price change (YTD)
-1.8%
Price change (1Y)
-16.0%
Trailing year
Price change (5Y)
+125.9%
52-week high
$84.48
52-week low
$51.87
Change from 52-week high
-17.1%
Change from 52-week low
+35.0%
Annualized volatility
42.0%
Annualized volatility (3M)
37.4%
Beta
1.0
RSI (14D)
48.0
Price vs SMA 50
-3.7%
Price vs SMA 200
+7.5%
Avg volume (3M)
671,311
Relative volume
0.5
Average dollar volume
$48.57M

Company

3 metrics
Sector
Healthcare
Industry
Diagnostics & Research
Shares outstanding
78.70M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
2.7×
reciprocal yield 36.9%
EV / EBITDA
25.4×
reciprocal yield 3.9%
EV / EBIT
86.8×
reciprocal yield 1.2%
P / sales
2.4×
reciprocal yield 41.0%
P / book
5.1
reciprocal yield 19.8%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
17.9
reciprocal yield 5.6%
Earnings yield
-0.4%

Historical valuation

8 metrics
P / E historical average (3Y)
327.5×
reciprocal yield 0.3%
P / E historical average (5Y)
264.3×
reciprocal yield 0.4%
EV / revenue historical average (3Y)
2.6×
reciprocal yield 38.0%
EV / revenue historical average (5Y)
2.2×
reciprocal yield 46.2%
EV / EBIT historical average (3Y)
64.4×
reciprocal yield 1.6%
EV / EBIT historical average (5Y)
53.2×
reciprocal yield 1.9%
EV / EBITDA historical average (3Y)
22.0×
reciprocal yield 4.5%
EV / EBITDA historical average (5Y)
18.0×
reciprocal yield 5.6%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-10

Profitability

9 metrics
Gross margin
—
Operating margin
3.1%
Trailing 12 months
Net margin
-0.9%
Gross profit (TTM)
$154.49M
Operating profit (TTM)
$70.78M
Net income (TTM)
−$21.12M
Trailing 12 months
Diluted EPS (TTM)
$-0.26
FCF margin
—
Effective tax rate
44.9%

Per share

11 metrics
Revenue per diluted share (TTM)
$29.59
Gross profit per diluted share (TTM)
$1,468.19
Operating profit per diluted share (TTM)
$0.92
EBITDA per diluted share (TTM)
$3.16
Net income per diluted share (TTM)
$-0.28
Operating cash flow per diluted share (TTM)
$4.05
Free cash flow per diluted share (TTM)
$191.25
Capital expenditures per diluted share (TTM)
$781.64
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
$0.77
Book value per share
$14.08

Growth

11 metrics
Revenue growth YoY
+25.0%
Year over year
Net income growth YoY
-47.9%
Revenue (TTM)
$2.27B
Trailing 12 months
EPS growth YoY
-47.4%
Shares change YoY
+4.2%
Year over year · more shares
Revenue CAGR (3Y)
+12.6%
Revenue CAGR (5Y)
+13.7%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
-2.3%
FCF CAGR (5Y)
+18.3%

Quality

14 metrics
Return on equity
-1.9%
Return on assets
-0.5%
Debt / equity
1.2
Current ratio
1.5
EBITDA (TTM)
$241.93M
Free cash flow (TTM)
—
Quick ratio
1.5
Interest coverage
—
Net debt / EBITDA
2.5
Return on invested capital
2.3%
Trailing 12 months
Net cash
−$606.26M
Latest balance sheet
Cash & equivalents
$726.27M
Total assets
$4.23B
Total debt
$1.33B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$310.06M
Capital expenditures (TTM)
$74.15M
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
$59.28M
R&D / revenue
—
Stock compensation / revenue
2.6%

Ownership (13F)

9 metrics
13F filers
331
13F filer change QoQ
-12
Institutional ownership
103.5%
Conviction holders (share of 13F filers)
1.2%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+4.3%
Holder tenure
15.2
Price vs estimated holder cost
+10.9%

Ownership (registered funds)

1 metrics
Index-fund ownership
25.6%

Short interest

3 metrics
Short interest
11.5%
Latest settlement · 17.1 days to cover
Days to cover
17.1d
Short-squeeze score
72 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 790526 CUSIP 750491102 13F (30d) 61 filings 61 filers Visit website Investor relations